Anthony Rosenberg
Global Head of Business Development & Licensing, Novartis Pharma
Anthony Rosenberg is Head of Business Development and Licensing (BD&L) and a member of the Pharma Executive Committee. He joined Sandoz in 1980 in the UK where he held various leadership positions in sales and marketing, business development and strategic planning. In 1994 he moved to Basle, initially as international product manager (Clozaril), and undertook roles of increasing responsibility in Global Marketing, ultimately as Head Global Marketing Primary Care.
In 2000 he became Global Head of the Transplant and Immunology Business Unit and began his current role in 2005. During this time Novartis has been amongst the most active companies in the BD&L arena. He has overseen several major in-licensing transactions in the respiratory, dermatology, infectious disease, CNS, transplant and ophthalmology areas Tony Rosenberg has a BSc (Biological Sciences) University of Leicester, and an M.Sc (Physiology) University of London.